| JYHZ2100646 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | License Renew | 2021-10-09 | | | | | view |
| JYHS2300009 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(5.2) | Import Drug Application | 2023-02-03 | | Natco Pharma Ltd | | | view |
| JYHB2400574 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2024-10-28 | | | | | view |
| JYHB2400150 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2024-04-08 | | | | | view |
| JYHB2200549 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2022-10-12 | | | | | view |
| JYHB2200458 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2022-08-19 | | | | | view |
| JYHB2200236 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2022-04-24 | | | | | view |
| JYHB2101476 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2021-10-21 | | | | | view |
| JYHB2100105 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2021-02-02 | Janssen-Cilag International NV | Janssen-Cilag International NV | Certificate Issued | 2021-03-09 | view |
| JYHB2100088 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2021-01-22 | Pharmacyclics LLC | Pharmacyclics Inc | In Review | 2021-01-21 | view |
| JYHB2001826 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-09-19 | Pharmacyclics LLC | Pharmacyclics Inc | In Review | 2020-09-18 | view |
| JYHB2000627 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-05-25 | Pharmacyclics LLC | Pharmacyclics Inc | Filed | 2020-06-04 | view |
| JYHB2000345 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-04-10 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2020-06-12 | view |
| JYHB2000254 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2020-03-14 | Pharmacyclics LLC | Pharmacyclics Inc | Filed | 2020-03-26 | view |
| JYHB1900652 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(2.4) | Supplementary Application | 2019-06-03 | Janssen Research & Development, LLC | Janssen Research & Development LLC | In Review | 2019-06-01 | view |
| JYHB1900651 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(2.4) | Supplementary Application | 2019-06-03 | Janssen Research & Development, LLC | Janssen Research & Development LLC | In Review | 2019-06-01 | view |
| JYHB1900203 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2019-02-22 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2019-04-04 | view |
| JYHB1800207 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2018-03-05 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2018-11-09 | view |
| JYHB1701213 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2017-09-26 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2018-07-06 | view |
| JYHB1701174 | 伊布替尼胶囊 | ibrutinib | Capsule | Chemical Drugs | Supplementary Application | 2017-09-18 | Pharmacyclics LLC | Pharmacyclics Inc | Certificate Issued | 2018-04-18 | view |
